Osteo Bi-Flex

Osteo Bi-Flex Ease

Serving
1 Tablet(s)
Form
tablet
DSLD
Formula hash
31330de28409
Brand context
Catalog
94
products
With avoid flag
16
products
FDA recalls
0
history
CAERS
81
reports
Avoid-flaggedObjective label signals
Flagged excipients
1
1 avoid · 0 caution
FDA recalls
0
no recall history
CAERS reports
19
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

3 active ingredients
IngredientAmount% DV
Vitamin D
vitaminUNII · 9VU1KI44GP
UL · set4 effects
10 mcg50%
Joint Shield 5-Loxin Advanced Boswellia serrata extract
Boswelliaherb
100 mg
UC-II Standardized Cartilage
Cartilageother
40 mg
What this product supports · authorized claims

4 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

Flagged excipients

1 flagged · authority citations

  • ● AVOIDTitanium Dioxide color
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

FDA CAERS · adverse event context
19
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Calcium Carbonate · Cellulose · Cellulose Coating · Stearic Acid · Croscarmellose · Polydextrose · Contains Less Than 2% of

Chemically equivalent

Same formula, different brand

Products with identical sorted (ingredient, amount) tuples.